Eli Lilly Q4 Profits Hurt by Generic Competition

29.01.2013 - Eli Lilly said on Tuesday that fourth-quarter profit fell as competition from generic drugs, particularly for its once top-selling schizophrenia drug Zyprexa, drove revenue lower...